PolyPeptide Group AG (LON:0AAJ)
London
· Delayed Price · Currency is GBP · Price in CHF 16.06
0.00 (0.00%)
At close: Apr 17, 2025
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 523.12 million as of April 24, 2025. Its market cap has decreased by -36.98% in one year.
Market Cap
523.12M
Enterprise Value
554.46M
Revenue
278.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.06
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.04B to 523.12M, a decrease of -74.35%. That is a compound annual growth rate of -28.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 523.12M | -36.61% |
| Dec 30, 2024 | 825.31M | 53.37% |
| Dec 29, 2023 | 538.12M | -28.11% |
| Dec 30, 2022 | 748.55M | -79.59% |
| Dec 30, 2021 | 3.67B | 79.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 157.23B |
| GSK plc | 55.19B |
| Haleon | 34.87B |
| Smith & Nephew | 8.58B |
| ConvaTec Group | 5.21B |
| Hikma Pharmaceuticals | 4.15B |
| HUTCHMED (China) | 2.01B |
| Oxford Nanopore Technologies | 1.13B |